Literature DB >> 6937155

Why HLA-B27: an analysis based on two animal models.

J T Rosenbaum.   

Abstract

The histocompatibility antigen HLA-B27 predisposes to at least three diseases: ankylosing spondylitis, Reiter's syndrome, and acute anterior uveitis. Despite its marked association with these diseases, the mechanism of the predisposition remains speculative. Two animal models, those of adjuvant arthritis and endotoxin-induced uveitis, are particularly relevant to an understanding of B27-related disease. An analysis of these two models is useful in considering hypotheses on the mechanism of the B27-related predisposition. The proposal that HLA-B27 itself or a gene closely linked to it confers an enhanced sensitivity to an inflammatory mediator such as a prostaglandin fits both with the animal models and observations on human disease. Studies to test this hypothesis are in progress.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6937155     DOI: 10.7326/0003-4819-94-2-261

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  10 in total

Review 1.  Immune functions and inflammatory reactions in HLA-B27 positive subjects.

Authors:  R Tertti; P Toivanen
Journal:  Ann Rheum Dis       Date:  1991-10       Impact factor: 19.103

2.  Determination of oxygen radical production in spondyloarthropathies by whole blood chemiluminescence.

Authors:  M Ristola; M Leirisalo-Repo; H Repo
Journal:  Ann Rheum Dis       Date:  1991-11       Impact factor: 19.103

3.  Complement activation and HLA-B27.

Authors:  S Meri; J Partanen; M Leirisalo-Repo; H Repo
Journal:  Ann Rheum Dis       Date:  1988-03       Impact factor: 19.103

4.  Polymorphonuclear leucocyte function and previous yersinia arthritis: enhanced chemokinetic migration and oxygen radical production correlate with the severity of the acute disease.

Authors:  P Koivuranta-Vaara; M Leirisalo-Repo; H Repo
Journal:  Ann Rheum Dis       Date:  1987-04       Impact factor: 19.103

5.  Antibodies to peptidoglycan in patients with spondylarthritis: a clue to disease aetiology?

Authors:  H Park; H R Schumacher; A R Zeiger; J T Rosenbaum
Journal:  Ann Rheum Dis       Date:  1984-10       Impact factor: 19.103

6.  Ocular albumin fluorophotometric quantitation of endotoxin-induced vascular permeability.

Authors:  S W Cousins; J T Rosenbaum; R B Guss; P R Egbert
Journal:  Infect Immun       Date:  1982-05       Impact factor: 3.441

7.  Time for a gut check: evidence for the hypothesis that HLA-B27 predisposes to ankylosing spondylitis by altering the microbiome.

Authors:  James T Rosenbaum; Michael P Davey
Journal:  Arthritis Rheum       Date:  2011-11

8.  Inhibition of polymorphonuclear leucocyte functions in vivo by Yersinia enterocolitica lipopolysaccharide.

Authors:  K T Hartiala; I Granberg; A Toivanen; M Viljanen
Journal:  Ann Rheum Dis       Date:  1989-01       Impact factor: 19.103

9.  Production of tumour necrosis factor and interleukin 1 by monocytes of patients with previous Yersinia arthritis.

Authors:  H Repo; M Jäättelä; M Leirisalo-Repo; M Hurme
Journal:  Clin Exp Immunol       Date:  1988-06       Impact factor: 4.330

10.  The effect of endotoxin and endotoxin tolerance on inflammation induced by mycobacterial adjuvant.

Authors:  J T Rosenbaum; R B Mandell
Journal:  Yale J Biol Med       Date:  1983 Jul-Aug
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.